296 related articles for article (PubMed ID: 36403186)
1. Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models.
Seyran M; Melanie S; Philip S; Amiq G; Fabian B
Clin Exp Med; 2023 Aug; 23(4):1075-1088. PubMed ID: 36403186
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
Williamson JD; Sadofsky LR; Hart SP
Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury.
Smith MR; Gangireddy SR; Narala VR; Hogaboam CM; Standiford TJ; Christensen PJ; Kondapi AK; Reddy RC
Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L616-25. PubMed ID: 20061443
[TBL] [Abstract][Full Text] [Related]
5. The Bleomycin Model of Pulmonary Fibrosis.
Liu T; De Los Santos FG; Phan SH
Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
[TBL] [Abstract][Full Text] [Related]
6. Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.
Vittal R; Walker NM; McLinden AP; Braeuer RR; Ke F; Fattahi F; Combs MP; Misumi K; Aoki Y; Wheeler DS; Wilke CA; Huang SK; Moore BB; Cao P; Lama VN
Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L39-L51. PubMed ID: 37933452
[TBL] [Abstract][Full Text] [Related]
7. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
8. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.
Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y
Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204
[TBL] [Abstract][Full Text] [Related]
9. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.
He F; Zhou A; Feng S
PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice.
Shi K; Jiang J; Ma T; Xie J; Duan L; Chen R; Song P; Yu Z; Liu C; Zhu Q; Zheng J
Respir Physiol Neurobiol; 2014 Jan; 190():113-7. PubMed ID: 24140943
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585
[TBL] [Abstract][Full Text] [Related]
12. Immune Mechanisms of Pulmonary Fibrosis with Bleomycin.
Ishida Y; Kuninaka Y; Mukaida N; Kondo T
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834561
[TBL] [Abstract][Full Text] [Related]
13. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.
Lino Cardenas CL; Henaoui IS; Courcot E; Roderburg C; Cauffiez C; Aubert S; Copin MC; Wallaert B; Glowacki F; Dewaeles E; Milosevic J; Maurizio J; Tedrow J; Marcet B; Lo-Guidice JM; Kaminski N; Barbry P; Luedde T; Perrais M; Mari B; Pottier N
PLoS Genet; 2013; 9(2):e1003291. PubMed ID: 23459460
[TBL] [Abstract][Full Text] [Related]
14. CD4(+)CD25(hi)Foxp3(+) Cells Exacerbate Bleomycin-Induced Pulmonary Fibrosis.
Birjandi SZ; Palchevskiy V; Xue YY; Nunez S; Kern R; Weigt SS; Lynch JP; Chatila TA; Belperio JA
Am J Pathol; 2016 Aug; 186(8):2008-2020. PubMed ID: 27317904
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.
Tang X; Peng R; Phillips JE; Deguzman J; Ren Y; Apparsundaram S; Luo Q; Bauer CM; Fuentes ME; DeMartino JA; Tyagi G; Garrido R; Hogaboam CM; Denton CP; Holmes AM; Kitson C; Stevenson CS; Budd DC
Am J Pathol; 2013 Aug; 183(2):470-9. PubMed ID: 23759512
[TBL] [Abstract][Full Text] [Related]
16. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis.
Heukels P; van Hulst JAC; van Nimwegen M; Boorsma CE; Melgert BN; von der Thusen JH; van den Blink B; Hoek RAS; Miedema JR; Neys SFH; Corneth OBJ; Hendriks RW; Wijsenbeek MS; Kool M
Respir Res; 2019 Oct; 20(1):232. PubMed ID: 31651327
[TBL] [Abstract][Full Text] [Related]
18. Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.
Kamio K; Azuma A; Matsuda K; Usuki J; Inomata M; Morinaga A; Kashiwada T; Nishijima N; Itakura S; Kokuho N; Atsumi K; Hayashi H; Yamaguchi T; Fujita K; Saito Y; Abe S; Kubota K; Gemma A
Respir Res; 2018 Apr; 19(1):71. PubMed ID: 29690905
[TBL] [Abstract][Full Text] [Related]
19. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
20. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.
Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE
Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]